Results 101 to 110 of about 45,950 (145)

Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review. [PDF]

Ann Surg Oncol
Liguori L, Ventin M, Cattaneo G, Zhang L, Osipov A, Sabbatino F, Ferrone CR.   +6 more
europepmc   +1 more source

Clinical and Pathological Characteristics and Treatment Implications of <i>BRCA1</i>- and <i>BRCA2</i>-Mutated Breast Cancer in Japanese Patients: A Single-Institution Retrospective Study. [PDF]

Breast Cancer (Auckl)
Akita Y, Iwase M, Kikumori T, Takeuchi D, Takano Y, Ichikawa T, Masuda N.   +6 more
europepmc   +1 more source

Novel Insights into the Enigmatic Genetics of Male Breast Cancer in China. [PDF]

Pathophysiology
Lang GT, Weng XL, Liu Y, Hu X, Shao ZM, Hu Z.   +5 more
europepmc   +1 more source

Revisiting the impact of BRCA1 pathogenic variants on the aggressiveness of prostate cancer. [PDF]

JNCI Cancer Spectr
Sasagawa H, Narita S, Matsuda K, Kosaka T, Momozawa Y.   +4 more
europepmc   +1 more source

Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomy. [PDF]

Hered Cancer Clin Pract
Metcalfe KA, Kinney AY, Narod SA, Poll A, Armel S, Lombardi L, Tavangar F, Pal T.   +7 more
europepmc   +1 more source

Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience. [PDF]

BMC Cancer
Abdel-Razeq H, Saleh Y, Hani HB, Abdel-Razeq R, Mohamad I, Sharaf B, Tamimi F, Abu-Jaish H, Al-Atary A, Aljabri A, Alnajjar R, Sammour M, Ghanem A, Amarin R, Awabdeh T.   +14 more
europepmc   +1 more source

Deleterious BRCA2 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Disease- and gene-specific deep learning for pathogenicity prediction of rare missense variants in cancer predisposition genes. [PDF]

BioData Min
Lee DB, Kang HU, Hwang KB.
europepmc   +1 more source

A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2. [PDF]

BJC Rep
Grindedal EM, Zucknick M, Hovland ST, Grimsrud TK, Mæhle L.   +4 more
europepmc   +1 more source